Novel Opportunities to Use Radiation Therapy with Immune Checkpoint Inhibitors for Melanoma Management
Author:
Publisher
Elsevier BV
Subject
Oncology,Surgery
Reference66 articles.
1. Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial;Ribas;Lancet Oncol,2015
2. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05;Shaw;Int J Radiat Oncol Biol Phys,2000
3. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial;Burmeister;Lancet Oncol,2012
4. The convergence of radiation and immunogenic cell death signaling pathways;Golden;Front Oncol,2012
5. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy;Apetoh;Nat Med,2007
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Determination of Interactive States of Immune Checkpoint Regulators in Lung Metastases after Radiofrequency Ablation;Cancers;2022-11-22
2. Red Light Phototherapy Using Light-Emitting Diodes Inhibits Melanoma Proliferation and Alters Tumor Microenvironments;Frontiers in Oncology;2022-06-24
3. Ultrasound-mediated immune regulation in tumor immunotherapy;Materials Today Advances;2022-06
4. Radiotherapy in the Treatment of Subcutaneous Melanoma;Cancers;2021-11-22
5. Immunotherapy and radiotherapy in melanoma: a multidisciplinary comprehensive review;Human Vaccines & Immunotherapeutics;2021-04-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3